Skip to content

Loading your page…

Active substance · J07BA01

Tick-borne encephalitis vaccine

On 2 registers3 medicines2 companies

See every medicineAsk Osler about it

Classification

Anatomical main groupJAnti-infectives for systemic use
Therapeutic subgroupJ07
Pharmacological subgroupJ07B
Chemical subgroupJ07BA
Chemical substanceJ07BA01Encephalitis, tick borne, inactivated, whole virus

Where it is registered

Each register with its number of medicines and a few of them.

United States
FDA · 2 medicines
- Ticovac1.2UG/0.25ML · Injection · Pfizer Ireland Pharmaceuticals Unlimited Company
- Ticovac2.4UG/0.5ML · Injection · Pfizer Ireland Pharmaceuticals Unlimited Company
Canada
Health Canada · 1 medicine · Historical list
- Fsme-Immun2.4 MCG / 0.5 ML · Suspension · Baxter Corporation

All medicines with Tick-borne encephalitis vaccine

Every register, a page at a time. Strengths and packs are on each medicine’s page.

3 results

Medicine	Register	Strength	Form	Status	Holder
Ticovac	United States	1.2UG/0.25ML	Injection	Marketed	Pfizer Ireland Pharmaceuticals Unlimited Company
Ticovac	United States	2.4UG/0.5ML	Injection	Marketed	Pfizer Ireland Pharmaceuticals Unlimited Company
Fsme-Immun	Canada	2.4 MCG / 0.5 ML	Suspension	Cancelled	Baxter Corporation

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.